Global Cord Blood & Tissue Banking Industry Report 2025-2032: Market Size, Competitive Landscape, Segmentation, & Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cord Blood & Tissue Banking Industry Report – Market Size, Segmentation, & Forecasts, 2025”... Read more.
Affinia Therapeutics Announces Series C Financing to Advance New Class of Gene Therapies Intended to Provide Improved Safety and Efficacy
New Enterprise Associates led the round with support from new investor, Eli Lilly & Company, and existing investors Financing supports IND submission and clinical... Read more.
DemeRx Awarded $1.7 Million National Institutes of Health Grant to Advance Potential First-in-Class Neuroplastogen Drug Candidate DMX-1001 for Alcohol Use Disorder (AUD)
DMX-1001 (noribogaine) is being developed to treat AUD through a potential novel mechanism that targets multiple areas of the central nervous system and promotes... Read more.
Smart City Platforms Global Market Forecast Report 2025-2030, Major Vendors are IBM, Siemens, Cisco, Hitachi, Microsoft, Huawei, AWS, AT&T, Nokia, and Atos – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smart City Platforms Market by Offering (Platforms, Services), Deployment (Cloud, On-premises, Hybrid), Application... Read more.
Redwire Announces Planned Board Refreshment
General (RET) James McConville and Dorothy D. Hayes to Join as Independent Directors; Jonathan Baliff and John S. Bolton to Step Down from the Board, Effective Immediately... Read more.
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
– ARO-DIMER-PA is designed to selectively silence the expression of two genes with a single RNAi molecule using Arrowhead’s proprietary TRiMTM technology... Read more.
Progentos Therapeutics Names Paul Frohna Chief Medical Officer
Veteran Translational Medicine and Clinical Development Leader Joins as Company Prepares to Advance its Lead Program for Remyelination in Multiple Sclerosis to Human... Read more.
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK... Read more.
SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy
New data demonstrates the ability of UMD technology to deliver genetic medicines, allowing for full-length human dystrophin protein expression in skeletal, heart... Read more.
Novata Acquires Atlas Metrics to Power the Future of Sustainability Data Management
Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets NEW YORK–(BUSINESS WIRE)–Novata,... Read more.